A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic-Reference-Cited by-同舟云学术

A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic

Published:2016-03-22 Issue:3 Volume:11 Page:e0150428
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Veguilla Vic,López-Gatell Hugo,López-Martínez Irma,Aparicio-Antonio Rodrigo,Barrera-Badillo Gisela,Rojo-Medina Julieta,Gross Felicia Liaini,Jefferson Stacie N.,Katz Jacqueline M.,Hernández-Ávila Mauricio,Alpuche-Aranda Celia M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference17 articles.

1. Characterizing the Epidemiology of the 2009 Influenza A/H1N1 Pandemic in Mexico;G Chowell;PLoS Med,2011

2. Seroprevalence to Influenza A(H1N1) 2009 Virus—Where Are We?;EE Broberg;Clinical and Vaccine Immunology,2011

3. Attack Rates Assessment of the 2009 Pandemic H1N1 Influenza A in Children and Their Contacts: A Systematic Review and Meta-Analysis;A Glatman-Freedman;PLoS ONE,2012

4. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries;MD Van Kerkhove;Influenza Other Respi Viruses,2013

5. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus;Wkly Epidemiol Rec,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mexico: Lessons learned from the 2009 pandemic that help us fight COVID-19;Healthcare Management Forum;2020-05-06

2. Seroprevalence of Zika virus among blood donors before the epidemic in Barranquilla, Colombia, 2015-2016.;Anais da Academia Brasileira de Ciências;2019

3. Clinical and laboratory findings of patients with the possible diagnosis of influenza hospitalized in affiliated hospitals of Babol University of Medical Sciences, 2015-2016;Current Issues in Pharmacy and Medical Sciences;2018-09-01

4. MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico;Human Vaccines & Immunotherapeutics;2018-01-03